Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   01/01/2023 - 06/30/2023
Lobbyist name Jennifer Herz   
Business name Boehringer Ingelheim Pharmaceuticals, Inc.
Address 900 Ridgebury Road   
City, state, zip code Ridgefield, CT 06877         
Country US
Agent type Both
Phone 860-970-4404
 
 
Operating Expenses
No operating expenses were filed for this disclosure reporting period.
 
Activities, Bill Numbers and Titles
Client: Boehringer Ingelheim Pharmaceuticals, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1150 An Act to ensure access to generic medication Neutral $345.96 N/A
Senate Bill 605 An Act empowering health care consumers Neutral $345.96 N/A
Senate Bill 1126 An Act promoting pet safety aka Crawford's Law Neutral $691.92 N/A
House Bill 1206 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $115.32 N/A
Senate Bill 630 An Act ensuring access to specialty medications Neutral $2,075.76 N/A
Senate Bill 1419 An Act to prevent undue influence on prescriber behavior Neutral $691.92 N/A
House Bill 959 An Act prohibiting discrimination against 340b drug discount program participants Neutral $2,767.68 N/A
House Bill 2249 An Act relative to the availability of prescription medication during an emergency Neutral $230.64 N/A
House Bill 943 An Act to reduce co-pays for people with chronic conditions Support $1,383.84 N/A
House Bill 1247 An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth Neutral $922.56 N/A
Senate Bill 732 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $2,767.68 N/A
House Bill 999 An Act empowering health care consumers Neutral $691.92 N/A
Senate Bill 580 An Act further protecting research animals Neutral $691.92 N/A
Senate Bill 767 An Act to define modest meals and refreshments in prescriber education settings Neutral $691.92 N/A
House Bill 863 An Act relative to proper disposal of products containing PFAS Neutral $2,075.76 N/A
House Bill 1215 An Act relative to pharmacy benefit managers Neutral $922.56 N/A
Senate Bill 704 An Act prohibiting discrimination against 340b drug discount program participants Neutral $2,767.68 N/A
Executive Executive Office of Health and Human Services (EOHHS) SD2595: Communication from the Executive Office of Health and Human Services (pursuant to Section 13L of Chapter 118E of the General Laws) submitting its 340B high-cost drugs impact report. Neutral $2,767.68 N/A
House Bill 982 An Act relative to non-medical switching Support $691.92 N/A
Senate Bill 479 An Act protecting pollinators by eliminating harmful products Neutral $691.92 N/A
House Bill 937 An Act relative to transparency of consumer health insurance rights Neutral $691.92 N/A
House Bill 1246 An Act relative to drug prices paid by carriers Neutral $1,383.84 N/A
Senate Bill 714 An Act relative to pharmaceutical gag clauses Support $2,075.76 N/A
House Bill 1147 An Act ensuring access to specialty medications Neutral $691.92 N/A
Senate Bill 603 An Act promoting consumer choice in health care Neutral $345.96 N/A
Senate Bill 783 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Neutral $345.96 N/A
House Bill 1201 An Act to promote transparency in prescription drug prices Neutral $2,767.68 N/A
Senate Bill 612 An Act relative to promoting healthcare access and affordability for patients Neutral $2,767.68 N/A
Senate Bill 1418 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Neutral $1,383.84 N/A
House Bill 978 An Act relative to promoting healthcare access and affordability for patients Support $2,767.68 N/A
House Bill 3587 An Act to ensure access to prescription medications Neutral $345.96 N/A
House Bill 850 An Act concerning the use of animals in product testing Neutral $922.56 N/A
House Bill 1208 An Act establishing a state-wide drug repository program Neutral $345.96 N/A
Senate Bill 656 An Act to reduce the cost of pharmacy benefits Neutral $2,075.76 N/A
Senate Bill 1862 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Neutral $691.92 N/A
House Bill 1176 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Neutral $2,767.68 N/A
Senate Bill 609 An Act relative to consumer deductibles Support $691.92 N/A
Senate Bill 1356 An Act to protect Massachusetts public health from PFAS Neutral $2,075.76 N/A
House Bill 1055 An Act relative to pharmaceutical gag clauses Support $691.92 N/A
Senate Bill 602 An Act relative to transparency of consumer health insurance rights Neutral $691.92 N/A
Senate Bill 776 An Act limiting out of pocket expenses Neutral $922.56 N/A
House Bill 953 An Act relative to consumer deductibles Support $1,383.84 N/A
House Bill 2197 An Act to protect Massachusetts public health from PFAS Neutral $2,075.76 N/A
House Bill 945 An Act to ensure prescription drug cost transparency and affordability Neutral $2,767.68 N/A
House Bill 1718 An Act relative to the humane protection of animals Neutral $691.92 N/A
Senate Bill 749 An Act relative to pharmaceutical access, costs and transparency Neutral $2,767.68 N/A
    Total amount $61,465.56  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement